Skip to content

Three Quick Facts: Vast Resources, Wishbone Gold, Deltex Medical

*

Three things you need to know in the financial markets today from investment writer, Tony Cross.

#1. Vast Resources Zimbabwe diamond update

There’s a short update out today from Vast Resources LON:VAST who have been battling a case to recover a parcel of diamonds from the Zimbabwean central bank. Back in February the High Court mandated that the assets were to be returned to Vast as the rightful owner, but progress has been incredibly slow. Today’s update – the first in around six weeks – notes that as a result of elections in the country it has been unable to conclude the deal, something which may result in yet more of those gains from the original ruling being further eroded.

#2. Wishbone Gold’s positive early results from Australian drilling

Wishbone Gold LON:WSBN has provided a drilling update from its Cottesloe project in Western Australia. This has confirmed the significant mineralisation potential of the asset, with multiple elements being identified. Drill chips have been sent for further analysis and results will be due in 6-8 weeks time.

#3. Deltex Medical’s new tech expected to be revenue generating by year end

Deltex Medical Group LON:DEMG has interims to 30th June out today. Revenues are down around 10% but losses have been trimmed marginally. After what management describe as a challenging first half, the company managed to raise almost £2m in cash in August and use some of the proceeds to streamline the cost base by reducing headcount. There have been delays in launching the company’s new TrueVue monitor which has now been launched into UK and EU hospitals for final evaluation. This is expected to be revenue generating by the end of the year.

Invest with these platforms

Hargreaves Lansdown IG Interactive Brokers Interactive Investor Charles Stanley
IG Interactive Brokers Charles Stanley

Looking for great investing ideas? Sign up to our free newsletter.

Join our UK news channel on WhatsApp

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Admiral Markets

TMX
WisdomTree
ARK
FxPro
IG
Back To Top